Annual Total Liabilities
$13.69 M
-$30.59 M-69.09%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual total liabilities is $13.69 million, with the most recent change of -$30.59 million (-69.09%) on December 31, 2023.
- During the last 3 years, AVTX annual total liabilities has fallen by -$5.50 million (-28.68%).
- AVTX annual total liabilities is now -76.04% below its all-time high of $57.13 million, reached on December 31, 2021.
Performance
AVTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$77.38 M
-$44.54 M-36.53%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly total liabilities is $77.38 million, with the most recent change of -$44.54 million (-36.53%) on September 30, 2024.
- Over the past year, AVTX quarterly total liabilities has dropped by -$44.54 million (-36.53%).
- AVTX quarterly total liabilities is now -65.58% below its all-time high of $224.81 million, reached on March 31, 2024.
Performance
AVTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AVTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.1% | -36.5% |
| 3 y3 years | -28.7% | +74.7% |
| 5 y5 years | -72.3% | +98.5% |
AVTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.0% | at low | -65.6% | +465.3% |
| 5 y | 5-year | -76.0% | at low | -65.6% | +465.3% |
| alltime | all time | -76.0% | +146.1% | -65.6% | +2557.1% |
Avalo Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $77.38 M(-36.5%) |
| Jun 2024 | - | $121.92 M(-45.8%) |
| Mar 2024 | - | $224.81 M(+1542.3%) |
| Dec 2023 | $13.69 M(-69.1%) | $13.69 M(-6.1%) |
| Sep 2023 | - | $14.57 M(-53.3%) |
| Jun 2023 | - | $31.20 M(-26.6%) |
| Mar 2023 | - | $42.50 M(-4.0%) |
| Dec 2022 | $44.28 M(-22.5%) | $44.28 M(+14.8%) |
| Sep 2022 | - | $38.58 M(+1.0%) |
| Jun 2022 | - | $38.17 M(-31.3%) |
| Mar 2022 | - | $55.56 M(-2.8%) |
| Dec 2021 | $57.13 M(+197.7%) | $57.13 M(+3.8%) |
| Sep 2021 | - | $55.05 M(+29.5%) |
| Jun 2021 | - | $42.50 M(+40.8%) |
| Mar 2021 | - | $30.19 M(+57.3%) |
| Dec 2020 | $19.19 M(+27.0%) | $19.19 M(-6.9%) |
| Sep 2020 | - | $20.62 M(+10.7%) |
| Jun 2020 | - | $18.63 M(+0.5%) |
| Mar 2020 | - | $18.53 M(+22.6%) |
| Dec 2019 | $15.11 M | $15.11 M(-61.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $38.97 M(-7.0%) |
| Jun 2019 | - | $41.92 M(-19.0%) |
| Mar 2019 | - | $51.75 M(+4.9%) |
| Dec 2018 | $49.34 M(+230.1%) | $49.34 M(+2.6%) |
| Sep 2018 | - | $48.10 M(+12.1%) |
| Jun 2018 | - | $42.93 M(+5.3%) |
| Mar 2018 | - | $40.78 M(+172.8%) |
| Dec 2017 | $14.95 M(+168.7%) | $14.95 M(+145.7%) |
| Sep 2017 | - | $6.08 M(+108.9%) |
| Jun 2017 | - | $2.91 M(-26.9%) |
| Mar 2017 | - | $3.99 M(-28.3%) |
| Dec 2016 | $5.56 M(-35.1%) | $5.56 M(-38.2%) |
| Sep 2016 | - | $9.00 M(+18.4%) |
| Jun 2016 | - | $7.60 M(-5.6%) |
| Mar 2016 | - | $8.05 M(-6.1%) |
| Dec 2015 | $8.57 M(-77.8%) | $8.57 M(-77.6%) |
| Sep 2015 | - | $38.30 M(+286.7%) |
| Jun 2015 | - | $9.91 M(-74.4%) |
| Mar 2015 | - | $38.69 M(+0.1%) |
| Dec 2014 | $38.65 M(+68.6%) | $38.65 M |
| Dec 2013 | $22.92 M | - |
FAQ
- What is Avalo Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Avalo Therapeutics?
- What is Avalo Therapeutics annual total liabilities year-on-year change?
- What is Avalo Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly total liabilities year-on-year change?
What is Avalo Therapeutics annual total liabilities?
The current annual total liabilities of AVTX is $13.69 M
What is the all time high annual total liabilities for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total liabilities is $57.13 M
What is Avalo Therapeutics annual total liabilities year-on-year change?
Over the past year, AVTX annual total liabilities has changed by -$30.59 M (-69.09%)
What is Avalo Therapeutics quarterly total liabilities?
The current quarterly total liabilities of AVTX is $77.38 M
What is the all time high quarterly total liabilities for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total liabilities is $224.81 M
What is Avalo Therapeutics quarterly total liabilities year-on-year change?
Over the past year, AVTX quarterly total liabilities has changed by -$44.54 M (-36.53%)